PRECISESADS: Cross Sectional Study - Lupus patients and healthy donors
ELU-4-32DBAB-1
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Cross Sectional Study
- Project Title
- PRECISESADS Sustainability at ELIXIR LU
- Project website
- https://www.imi.europa.eu/projects-results/project-factsheets/precisesads
- Primary Purpose
- Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Cross Sectional Study
- Study Types
- observational
- Description of Cohorts
- 342 SLE patients(93,1% females) and 497 healthy controls (79,4% females)
- Informed Consent Given?
- True
- Multi-center Study?
- True
- Organisms
- Homo sapiens
- Number of subjects
- 839
- Diseases
- Systemic Lupus Erythematosus (SLE)
- Sample Sources
- tissue sample
- Type of Samples Collected
- Whole blood
- Cohort characteristics
-
47.0 ± 13.1 in healthy donors, 46.1 ± 13.8 in SLE patients- year
